24/7 Patient Assistance: 760-405-8205

Andrew Pippas , MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer

Hospitals & Clinics

specialties & services

Biological Therapy/Immunotherapy Chemotherapy Gene Therapy Pain Management Photodynamic Therapy Targeted Therapy

  • Education & Training

    dept_icon

    University of Utah School of Medicine

    Medical School

    dept_icon

    Duke University Hospital

    Residency

    dept_icon

    Duke University Hospital

    Fellowship

  • Board Certifications

    American Board of Internal Medicine

    American Board of Internal Medicine - Hematology

    American Board of Internal Medicine - Oncology

  • Publications & Memberships

    Dr. Andrew Pippas has contributed to 3 publications.

    High pathologic complete response in Her2-positive, early-stage breast cancer to a novel nonanthracycline neoadjuvant chemotherapy.

    Zelnak, A. B.,Nikolinakos, P.,Srinivasiah, J.,Jonas, W.,Pippas, A.,Liu, Y.,Li, X.,Torres, M.,O'Regan, R. M.; Clin. Breast Cancer. 2014 Jul 30.

    See more >>

    Multicenter phase II and translational study of cetuximab in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin, and fluoropyrimidines.

    Lenz, H., Van Cutsem, E., Khambata-Ford, S., Mayer, R.J., Gold, P., Stella, P., Mirtsching, B., Cohn, A.L., Pippas, A.W., Azarnia, N., Tsuchihashi, Z., Mauro, D.J., Ro...; J Clin Oncol. 2006 Oct 20.

    See more >>

    A case report of invasive ductal adenocarcinoma identified in a lymphatic channel: a staging controversy.

    Jakub, J.W., Drake, F.D., Pippas, A.W., Gardner, M., Fraile, R.J., Giuliano, R., Pendas, S., Reintgen, D.S.; Cancer Control. 2003-09-01.

    See more >>